UY33099A - DERIVATIVES OF 9H-PIRIDINO [3,4-B] INDOL DISPOSED, METHOD TO PREPARE THEM, SYNTHESIS INTERMEDIARIES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THE SAME IN CANCER THERAPY. - Google Patents

DERIVATIVES OF 9H-PIRIDINO [3,4-B] INDOL DISPOSED, METHOD TO PREPARE THEM, SYNTHESIS INTERMEDIARIES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THE SAME IN CANCER THERAPY.

Info

Publication number
UY33099A
UY33099A UY33099A UY33099A UY33099A UY 33099 A UY33099 A UY 33099A UY 33099 A UY33099 A UY 33099A UY 33099 A UY33099 A UY 33099A UY 33099 A UY33099 A UY 33099A
Authority
UY
Uruguay
Prior art keywords
piridino
indol
derivatives
prepare
disposed
Prior art date
Application number
UY33099A
Other languages
Spanish (es)
Inventor
Alexandre Gross
Serge Mignani
Didier Babin
Olivier Bedel
Thierry Gouyon
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY33099A publication Critical patent/UY33099A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UY33099A 2009-12-10 2010-12-10 DERIVATIVES OF 9H-PIRIDINO [3,4-B] INDOL DISPOSED, METHOD TO PREPARE THEM, SYNTHESIS INTERMEDIARIES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THE SAME IN CANCER THERAPY. UY33099A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0958830A FR2953837B1 (en) 2009-12-10 2009-12-10 DISUBSTITUTED 9H-PYRIDINO [3,4-B] INDOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE

Publications (1)

Publication Number Publication Date
UY33099A true UY33099A (en) 2011-07-29

Family

ID=42062609

Family Applications (1)

Application Number Title Priority Date Filing Date
UY33099A UY33099A (en) 2009-12-10 2010-12-10 DERIVATIVES OF 9H-PIRIDINO [3,4-B] INDOL DISPOSED, METHOD TO PREPARE THEM, SYNTHESIS INTERMEDIARIES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THE SAME IN CANCER THERAPY.

Country Status (5)

Country Link
AR (1) AR079328A1 (en)
FR (1) FR2953837B1 (en)
TW (1) TW201130833A (en)
UY (1) UY33099A (en)
WO (1) WO2011070298A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3407B1 (en) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd Tetrahydropyrazolopyrimidine Compounds
CN106588918B (en) * 2016-12-08 2019-02-19 广东省测试分析研究所（中国广州分析测试中心） A kind of preparation method and applications of 3- amino-beta-carboline
EP3860996A4 (en) 2018-10-02 2022-08-31 Northwestern University Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2c (5-ht2c)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same
DK240084D0 (en) * 1984-05-15 1984-05-15 Ferrosan As NEW BETA-CARBOLINE-3-OXADIAZOLYL DERIVATIVES
DE3540653A1 (en) * 1985-11-13 1987-05-14 Schering Ag NEW 3-OXADIAZOLE AND 3-CARBONIC ACID SS-CARBOLINE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
AU619203B2 (en) * 1987-08-28 1992-01-23 Schering Aktiengesellschaft Isoxazole-beta-carboline derivatives
US5502194A (en) 1992-02-19 1996-03-26 Bayer Aktiengesellschaft Process for the preparation of 2-halogeno-pyridine derivatives
DE4233708A1 (en) 1992-10-07 1994-04-14 Ruetgerswerke Ag Process for the preparation of pure 2,5-dichloropyridine and recovery of the 2,3-dichloropyridine obtained as a by-product
JPH11505217A (en) * 1995-05-05 1999-05-18 ノボ ノルディスク アクティーゼルスカブ New heterocyclic chemistry
WO2000063209A1 (en) * 1999-04-20 2000-10-26 Novo Nordisk A/S New compounds, their preparation and use
US6492406B1 (en) * 1999-05-21 2002-12-10 Astrazeneca Ab Pharmaceutically active compounds
EP1209158A1 (en) * 2000-11-18 2002-05-29 Aventis Pharma Deutschland GmbH Substituted beta-carbolines
US9248124B2 (en) * 2001-11-07 2016-02-02 Millennium Pharmaceuticals, Inc. Use of inhibitors of IκB kinase for the treatment of cancer
FR2869540B1 (en) * 2004-04-30 2008-05-16 Centre Nat Rech Scient Cnrse PHARMACEUTICAL COMPOSITIONS CONTAINING B-CARBOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER
US8119655B2 (en) * 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
AU2008237507B2 (en) * 2007-04-03 2014-03-20 Array Biopharma Inc. Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
GB0723815D0 (en) * 2007-12-05 2008-01-16 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
AR079328A1 (en) 2012-01-18
WO2011070298A1 (en) 2011-06-16
FR2953837A1 (en) 2011-06-17
FR2953837B1 (en) 2012-03-09
TW201130833A (en) 2011-09-16

Similar Documents

Publication Publication Date Title
GT201200321A (en) DERIVATIVES OF HETEROARIL IMIDAZOLONA AS JAK INHIBITORS
CL2014001158A1 (en) Alkylated piperazine derivative compounds; pharmaceutical composition that includes them; process to prepare the pharmaceutical composition; kit and use in the treatment of immune disorders, cancer, cardiovascular diseases, inflammation, among others.
CL2013003227A1 (en) "Substituted indazole-derived compounds, modulators of protein kinase activity; process of obtaining them; in vitro method to inhibit protein kinases; pharmaceutical composition and combination comprising them; and its use in the treatment of cancer "pct
CL2011003350A1 (en) Nitrogenous heterocycle derivative compounds, pkm2 modulators; pharmaceutical composition comprising them; and its use in the treatment of cancer.
CO6440531A2 (en) 2-ACETAMIDO-5-ARIL-1,2,4-SUBSTITUTED TRIAZOLONES AND ITS USE
SMT201600225B (en) DERIVATIVES OF 1,2,4-TIAZOLOLIN-3-0NE AND THEIR USE IN CANCER TREATMENT
CL2014001829A1 (en) Compounds derived from indolizine; preparation procedure; pharmaceutical compositions containing them and use in the treatment of cancer.
UY31918A (en) FGFR INHIBITING PIRAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, PROCESSES FOR THE PREPARATION AND USE AS A MEDICINAL PRODUCT
NI201100130A (en) PIRIMIDIN INDOLE DERIVATIVES FOR THE TREATMENT OF CANCER.
CL2012002189A1 (en) Compounds derived from substituted pyrrolidine-2-carboxamides; mdm2-p53 interaction inhibitors; pharmaceutical composition; and its use for the treatment of cancer, particularly solid tumors.
CO6541643A2 (en) IMIDAZOPIRINE DERIVATIVES AS JAK INHIBITORS
BRPI0810524A2 (en) (AZA) INDOL DERIVATIVE AND USE OF THE SAME FOR MEDICAL PURPOSES
UY29781A1 (en) DIAZASPIRO SUBSTITUTE COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS OR SALTS, PREPARATION METHODS AND USES
DOP2010000304A (en) COMPOSITIONS AND METHODS OF PREPARATION AND USE OF THE SAME
ECSP12012042A (en) PIRAZOL DERIVATIVES AS JAK INHIBITORS
GT201300137A (en) IMIDAZO DERIVATIVES [1,2-B] PIRIDAZINE AND IMIDAZO [4,5-B] PIRIDINA AS JAK INHIBITORS
SV2010003559A (en) SOME DERIVATIVES OF 2-PIRAZINONA AND ITS USE AS INHIBITORS OF ELASTASA DE LOS NEUTROFILOS
CL2008003473A1 (en) Heterocycle substituted phenylpiperidine derivative compounds; preparation procedure; pharmaceutical composition comprising it; and use in the treatment of cardiovascular, thromboembolic and tumor disorders; in vitro uses.
CO6920294A2 (en) Derivatives of estra-1,3,5 (10), 16-tetraen-3-carboxamide, procedures for their preparation, pharmaceutical preparations containing them, as well as their use for the preparation of medicines
CR10665A (en) NEW DERIVATIVES OF DIOSMETINE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CR10953A (en) NEW TRICYCLE DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CL2008002545A1 (en) Phenoxy-benzyl-carbamoyl derived compounds; pharmaceutical composition; process for preparing the pharmaceutical composition; and its use in the treatment of pain.
CL2007002919A1 (en) COMPOUNDS DERIVED FROM PIRIDO [2,3-B] INDOL, QUINASE INHIBITORS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT CANCER, AMONG OTHER DISEASES.
SV2010003773A (en) 7-SULFANILMETIL-, 7-SULFINILMETIL- AND 7-SULFONILMETILINDOLES REPLACED AND THE USE OF THE SAME
SV2010003753A (en) DRONEDARONA FOR THE PREVENTION OF CARDIOVERSION

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20190225